-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

803. Emerging Tools, Techniques and Artificial Intelligence in Hematology: Poster III

Symposia: Emerging Tools, Techniques and Artificial Intelligence in Hematology Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Edward Ayoub, PhD1*, Li Li, MD1*, Muharrem Muftuoglu, MD1, Yuki Nishida, MD, PhD1, Vakul Mohanty, PhD2*, Jake S Leighton3*, Tallie Patsilevas1*, Mahesh Basyal, BSc4*, Andrea Bedoy1*, Torsten Haferlach, MD, PhD5, Koichi Takahashi, MD, PhD6, Ken Chen, PhD2*, Nicholas Navin3*, Ghayas C. Issa7 and Michael Andreeff, MD PhD6

1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
5MLL Munich Leukemia Laboratory, Munich, Germany
6Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
7The University of Texas MD Anderson Cancer Center, Houston, TX

Xiao Xian Lin, BSc1*, Vedant Sandhu2*, Christopher A. Eide3*, Stephen E. Kurtz3*, Disha Malani, PhD4, Tom Erkers5*, Olli Kallioniemi6*, Jeffrey W Tyner, PhD3 and Shruti Bhatt, PhD7

1Department of Pharmacy, National University of Singapore, Singapore, SGP
2Department of Pharmacy, National University of Singapore, Singapore, Singapore, Singapore
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR
4Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
5Department of Oncology and Pathology, Karolinska Institutet, Solna, Stockholm, SWE
6Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Stockholm, Sweden
7Department of Pharmacy, National University of Singapore, Singapore, Singapore

Arda Durmaz, PhD1*, Sean Yetter1*, Tariq Kewan, MBBChir2, Waled Bahaj, MD3, Carlos Bravo-Perez, MD, PhD1*, Luca Guarnera, MD1*, Naomi Kawashima, MD, PhD1*, Hussein Awada1*, Carmelo Gurnari, MD1*, Yasuo Kubota, MD, PhD4*, Jacob Scott1*, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP1 and Valeria Visconte, PhD1

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT
3Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH
4Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Beachwood, OH

Blanca Ferrer Lores, MD1*, Alicia Serrano, PhD1*, Rafael Hernani2*, Pablo Sopena-Novales, MD3*, Laura Ventura Lopez4*, Ana Isabel Teruel, MD1*, Alfonso Ortiz Algarra, MD1*, Ana Saus Carreres5*, Ignacio Arroyo Martin, MD1*, Alexandru Robert Vasile Tudorache1*, Jose Luis Pinana Sanchez, MD, PhD5*, Juan Carlos Hernandez Boluda, MD, PhD6*, Ariadna Perez7*, Ana Benzaquen, MD8*, Aitana Balaguer Rosello, MD, PhD9*, Manuel Guerreiro, MD, PhD10*, Jaime Sanz, MD, PhD11*, Almudena Fuster-Matanzo, PhD12*, Alfonso Picó, PhD12*, Alejandra Estepa-Fernández, PhD12*, Juan Pedro Fernández12*, Fuensanta Bellvís-Bataller12*, Glen J Weiss, MD13*, Carlos Solano, MD, PhD8 and Maria José Terol, MD, PhD14*

1Department of Hematology, Hospital Clínico Universitario-INCLIVA, Valencia, Spain
2Clinical Univesity Hospital of Valencia, Valencia, Spain
3Servicio de Medicina Nuclear, Hospital Vithas-Nisa 9 de Octubre y Hospital Universitario y Politécnico La Fe, Valencia, Spain
4Department of Hematology, Hospital Clínico Universitario-INCLIVA, VALENCIA, Spain
5Department of Hematology, Hospital Clínico Universitario-INCLIVA, Valencia, ESP
6Hospital Clínico Universitario-INCLIVA, Valencia, Spain
7Hospital Clínico Universitario, Valencia, Spain
8Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain
9Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, España, Valencia, ESP
10Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
11Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, España, Valencia, Spain
12Quantitative Imaging Biomarkers in Medicine, Quibim, Valencia, Spain
13Chief Medical Officer, Quantitative Imaging Biomarkers in Medicine, Quibim, Boston, MA, USA, Boston, MA
14Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, ESP

Alexandru Socolov, MBAn1*, Penelope Lafeuille1*, Sheila Diamond, MS, CGC2*, Eric Yang, PhD1*, Francesco Maura, MD3, Jacob Aptekar, MD, PhD2* and Esther Nie, MD, PhD4*

1Medidata AI, Medidata, a Dassault Systemes Company, New York, NY
2Medidata AI, Medidata, a Dassault Systèmes company, New York, NY
3Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, PALMETTO BAY, FL
4Department of Neurology, Stanford University, Stanford, CA

Yu-Fen Wang1,2*, Guo-Hung Li, M.S.1*, Joseph R. Hanson3*, Joseph D. Tario Jr, Ph.D.4*, Sara A. Monaghan, M.D.5*, Bor-Sheng Ko, M.D. Ph.D.2,6,7*, Paul K. Wallace, Ph.D.8*, Kai Fu, MD, PhD4 and Yu Qian, Ph.D.9*

1AHEAD Intelligence Ltd, Taipei, Taiwan
2AHEAD Medicine Corporation, San Jose, CA
3Department of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, NY
4Department of Pathology & Laboratory Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
5Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA
6National Taiwan University Hospital, Taipei, Taiwan
7National Taiwan University Cancer Center, Taipei, Taiwan
8Roswell Park Comprehensive Cancer Center, Buffalo, NY
9J. Craig Venter Institute, San Diego, CA

Chunhui Xu1,2*, Xin Chen3*, Huiming Yi3*, Erlie Jiang, PhD3 and Sizhou Feng4*

1Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical S, TIANJIN, China
2Microbiology laboratoryv, Tianjin Union Precision Medical Diagnostic Co., Ltd, Tian jin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
4National Key Laboratory of Blood Science, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Yuefan Huang, Ph.D*, Alvin Shi, Ph.D*, Rita Shaknovich, MD, PhD, Oliver Venn, Ph.D* and Qinwen Liu, Ph.D*

GRAIL, LLC, Menlo Park, CA

Solomon Oshabaheebwa, MS1*, Christopher A. Delianides, MS2*, Zoe Sekyonda, BS3*, Yusang M. Bejarano Ley3*, Calvin Abonga, MS2*, Vivien A Sheehan, PhD4, Michael A. Suster, PhD1*, Pedram Mohseni, PhD1* and Umut A. Gurkan, PhD3,5

1Case Western Reserve University, Cleveland, OH
2Department of Electrical, Computer, and Systems Engineering, Case Western Reserve University, Cleveland, OH
3Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH
4Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA
5Department of Mechanical and Aerospace Engineering, Case Western Reserve University, Shaker Heights, OH

Kevin Lee, BSc1*, Melissa MacLiesh, M.S.2*, Cih-Li Hong2*, Wimeth Dissanayake2*, Yuko Kawano, MD, PhD3*, Hiroki Kawano, MD, PhD3*, Christina Kaszuba1*, Benjamin Rodems, MS4*, Judith M. Runnels, PhD5*, Michael W. Becker, MD6, Jeevisha Bajaj, PhD3, Charles Lin, PhD7*, Laura Calvi, MD2 and Shu-Chi Yeh, PhD8

1Department of Biomedical Engineering, University of Rochester, Rochester, NY
2University of Rochester, Rochester, NY
3University of Rochester Medical Center, Rochester, NY
4University of Rochester Medical Center, Rochester
5MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA
6Univ. of Rochester Medical Center, Rochester, NY
7Massachusetts General Hospital, Boston, MA
8Department of Orthopedics, Center of Musculoskeletal Research., University of Rochester Medical Center, Rochester, NY

Álvaro Díaz-González, MD1*, Cristian García-Ruiz, MSC1*, Gayane Avetisyan, MSC1*, Gloria Llorens, MSC1*, José Vicente Gil, MSC1*, Elvira Mora, MD, PhD1,2*, Santiago Furió, MD1,2*, Empar Mayordomo, MD, PhD3*, Carolina López-Benet, MSC1*, Marina Suárez-Terrón, MD2*, Mireya Morote-Faubel4*, Marta Santiago, MD1,5*, Samuel Romero, MD1*, Marta Llop, PhD6,7*, Eva Barragán, PhD6,7*, Lourdes Cordón, PhD1,7*, Alessandro Liquori, PhD1,7*, Dolores Linares, MD1,2*, Irene Luna, MD, PhD1,2*, Ana Vicente, MD1,2*, Rafael Andreu, MD, PhD1,2*, Amparo Sempere, MD, PhD1,2,7*, Leonor Senent, MD, PhD1,2,7*, José Cervera, MD, PhD1,2,7,8*, Guillermo Sanz, MD, PhD1,2,7, Javier De La Rubia5,7,9,10* and Esperanza Such, PhD1,2,7*

1Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
2Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
3Pathology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain
4Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, CA, Spain
5Hospital Universitario y Politécnico La Fe, Valencia, Spain
6Molecular Biology Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain
7Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
8Genetics Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain
9Hospital Universitario y Politécnico La Fe, Valencia, Spain
10Hospital Universitario La Fe, Valencia, Spain

Luca Biasiolli, DPhil1*, Arianna Campione2*, Pietro Ansaloni1*, Nicolò Gentili1*, Ramona Miserendino, PhD1*, Giulio Signorini1* and Gianni Medoro, PhD1*

1Menarini Silicon Biosystems, Bologna, Italy
2Polytechnic University of Bari, Bari, Italy

Jacob Shreve, MD1, Allison M. Bock, MD2, Izel Okcu3*, Antonious Hazim, MD4, Joshua C Pritchett, MD5*, Raphael Mwangi, M.S.5*, Matthew J. Maurer, DSc6, Mithun V Shah, MD, PhD3, Yucai Wang, MD, PhD3, Stephen M Ansell, MD, PhD3, Thomas M. Habermann, MD3, Thomas E. Witzig, MD5, James R. Cerhan, MD, PhD6, Jason R Young, MD7*, Moritz Binder, MD5, Grzegorz S. Nowakowski, MD3 and Jonas Paludo, MD5

1Mayo Clinic, Granger, IN
2Division of Hematology and Medical Oncology, Mayo Clinic, Rochester
3Division of Hematology, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester
5Mayo Clinic, Rochester, MN
6Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
7Mayo Clinic, Jacksonville, FL

Anne Benard-Slagter, PhD1*, Sander Palit, PhD1*, Charlotte Enright1*, Borbála Péterffy2*, Donát Alpár, PhD3*, Ivo Clemens4* and Suvi Savola, PhD1*

1Oncogenetics, MRC Holland, Amsterdam, Netherlands
21st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
3HCEMM-SU Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
4Software department, MRC Holland, Amsterdam, Netherlands

Javeria Aijaz, FCPS, PhD1*, Fouzia Naseer, MSc, MBA1*, Shakir Hussain, MSc, MPhil1*, Muhammad Rafie Raza, DCH, MCPS, FCPS2*, Saba Jamal, MBBS3*, Shamvil Ashraf, DCH, MCPS, FCPS, MRCP4*, Larissa Furtado, MD5*, Nickhill Bhakta, MD, MPH6*, Thomas B. Alexander, MD, MPH7 and Jeremy Wang, PhD8*

1Pathology Department, Indus Hospital & Health Network, Karachi, Pakistan
2Pediatric Hematology/Oncology Department, Indus Hospital & Health Network, Karachi, Pakistan
3Pathology Department, Indus Hospital & Health Network, Karachi, PAK
4Executive Director Medical Services, Indus Hospital & Health Network, Karachi, Pakistan
5Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
6Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN
7Department of Pediatrics, University of North Carolina, Chapel Hill, NC
8Department of Genetics, University of North Carolina, Chapel Hill, NC

Heidi Simmons, PhD1, Lik Wee Lee, PhD2*, April Lo, PhD2*, Kipp Akers, PhD2*, Ilan M. Kirsch, MD3 and Allison P. Jacob, MSc3

1Adaptive Biotechnologies Corporation, Seattle, WA
2Computational Biology, Adaptive Biotechnologies, Seattle, WA
3Medical Affairs, Adaptive Biotechnologies, Seattle, WA

Kazuki Taoka, MD, PhD1,2*, Arika Shimura-Nukina3*, Akira Honda, MD, PhD4*, Yosuke Masamoto, MD5 and Mineo Kurokawa, MD, PhD6

1Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, Tokyo, TKY, Japan
2Department of Clinical Application for Development of Therapy for Rare and Intractable Diseases, University of Tokyo, Tokyo, TKY, Japan
3Department of Hematology and Oncology, University of Tokyo, Tokyo, JPN
4The Department of Hematology and Oncology, the University of Tokyo Hospital, Bunkyoku, TKY, Japan
5Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan
6Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

David Kaplan1*, Eric Christian1*, Jason Valent, MD2, Faiz Anwer, MD2, Shahzad Raza, MD2*, Sandra Mazzoni, DO3, Christy J. Samaras, DO4, Louis S. Williams, MD5, Danai Dima, MD6, Kelly Shepherd4*, Jared Fennema4*, Sherry Fada3*, Megan Nakashima, MD7, Mazen Hanna8*, Hillard M. Lazarus, MD9 and Jack Khouri, MD2

1CellPrint Biotechnology, Cleveland
2Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
4Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland
5Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH
8Department of Cardiology, Section of Heart Failure and Cardiac Transplantation Medicine, Cleveland Clinic, Cleveland
9Case Western Reserve University, Cleveland, OH

Soroush Shahryari Fard1*, Theodore J. Perkins, PhD1,2* and Philip Stephen Wells, MD, MSc, FRCP1,3

1The Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada
2Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada
3Department of Medicine, University of Ottawa, Ottawa, ON, Canada

Constanza Marin1*, Maribel Nicola1*, Diego Andino1*, Maria Laura Bernaschini1*, Agustina Conrrero1*, Gimena Ferreira1*, Marisa Piaggio2*, Guillermina Remaggi, MD3*, Maria Sol Jarchum, MD4*, Gustavo Jarchum, MD4*, Rodrigo Meneces Bustillo, MD4*, Blanca de los Milagros Rossi5*, Juan José García, MD5*, Tarek Ali Zaki6*, Candelaria Llorens1*, Gerardo Gatti1*, Daniela Arroyo1* and Gastón Soria, PhD7*

1OncoPrecision, Córdoba, Argentina
2OncoPrecision, Buenos Aires, Argentina
3FUNDALEU, Buenos Aires, Argentina
4Sanatorio Allende, Córdoba, Argentina
5Hospital Italiano de Córdoba, Córdoba, Argentina
6OncoPrecision, New York City, NY
7OncoPrecision, Maplewood, NJ

Zeeshan Haider, DPhil1*, Jaweria Mughal1*, Neha Ahmed1*, Areeba Munir1*, Wendy N. Erber, MD PhD2, Ikram-Uddin Ujjan3* and Najeed Khan1*

1NED University of Engineering and Technology, Karachi, Pakistan
2School of Biomedical Sciences, University of Western Australia, Crawley, Australia
3Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan

Kerry A Morrone, MD1, Shweta Garg, MS2*, Boudewijn Aasman, BS3*, Erin Henninger, MPH3*, Mahendranath Rangareddy, M Tech3*, Deepa Manwani, MD4, Selvin Soby, PharmD3*, Parsa Mirhaji, MD PhD5* and Michael L Rinke, MD PhD6*

1Division of Pediatric Hematology, Oncology and Cellular Therapy, Children's Hospital At Montefiore, Bronx, NY
2Center for Health Data Innovations, Montefiore Medical Center, Bronx, NY
3Center for Health and Data Innovations, Montefiore Medical Center, Bronx, NY
4Department of Pediatric Hematology-Oncology, Albert Einstein College of Medicine, Bronx, NY
5Albert Einstein College of Medicine, Bronx, NY
6Children's Hospital at Montefiore, Bronx, NY

Julian Thull1*, Martina Crysandt, MD2,3*, Barbara Klinkhammer4*, Peter Boor5,6*, Tim H. Brümmendorf7,8, Volkmar Schulz1,9*, Barbara Klinkhammer, MD10*, Dorit Merhof11* and Edgar Jost, MD12,13*

1Institue for Experimental Molecular Imaging, RWTH Aachen, Aachen, Germany
2University Hospital RWTH Aachen, Aachen, DEU
3Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
4Department of Pathology, University Hospital aachen, Aachen, Germany
5Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany
6Institute of Pathology, RWTH Aachen University, Faculty of Medicine, Aachen, Germany
7Hematology/Oncology, Universitätsklinikum RWTH Aachen, Aachen, Germany
8Center for Integrated Oncology - Aachen Bonn Cologne Duesseldorf (CIO-ABCD), Aachen, Germany
9Fraunhofer Institue for Digital Medicine MEVIS, Bremen, Germany
10Department of Pathology, University Hospital Aachen, Aachen, Germany
11Institue of Image Analysis and Computer Vision, University of Regensburg, Regensburg, Germany
12Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital Aachen, Aachen, Germany
13Center for Integrated Oncology CIO ABCD Aachen, Bonn Cologne, Düsseldorf, Aachen, Germany

Bridget A Robinson, PhD1*, Philipp Sergeev, MSc2*, Yoko Kosaka, PhD3*, Thomas Jacob, PhD1*, Andy Kaempf, MS4*, Evan F. Lind, PhD5, Cristina Tognon, PhD1*, Luis A. Carvajal, PhD6*, Jorge F. DiMartino, MD6, Caroline A. Heckman, PhD7 and Tania Q Vu, PhD1*

1Oregon Health & Science University, Portland, OR
2Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
3Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR
4Department of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR
5Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR
6Kronos Bio, Inc., San Mateo, CA
7Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland

Gordana Raca, MD, PhD1, Alexandra E. Kovach, MD1*, Karin Miller, MD2*, Jennifer Han2*, Katherine Ma2*, Cindy Fong2*, Jianling Ji, MD, MS2*, Ryan Schmidt, MD, PhD2*, Andrew Doan, MD3* and Deepa Bhojwani, MD4

1Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
2Children's Hospital Los Angeles, Los Angeles, CA
3Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, CA
4Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA

Eric McGinnis, MD1,2, Zeid Hamadeh, PhD1,2*, Clare Jensen1* and Tara Spence, PhD, FCCMG1,2*

1Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada

Patrycja Dawiec, MSc1,2*, Paulina Laskowska3*, Patrycja Leszczenko, MSc1,4*, Anna Maria Nowakowska, PhD4*, Maciej Szydlowski, PhD5*, Przemysław Juszczyński, MD, PhD6*, Malgorzata Baranska, PhD4,7*, Katarzyna Majzner, PhD2* and Piotr Mrówka, PhD8,9*

1Doctoral School of Exact and Natural Sciences, Jagiellonian University, Kraków, Poland
2Department of Chemical Physics, Faculty of Chemistry, Jagiellonian University, Krakow, POL
3Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
4Department of Chemical Physics, Faculty of Chemistry, Jagiellonian University, Kraków, POL
5Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, POL
6Institute of Hematology and Transfusion Medicine, Warsaw, Poland
7Jagiellonian Centre for Experimental Therapeutics, Jagiellonian University, Kraków, Poland
8Department of Biophysics, Physiology, and Patophysiology, Medical University of Warsaw, Warsaw, Poland
9Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warszawa, AL, Poland

*signifies non-member of ASH